Therapeutic Asset Ratings
105 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
(3RS)-1-(6-(.ALPHA.-METHYLPOLY(OXYETHYLENE)AMINO)-6-OXOHEXYL)-2,5-DIOXOPYRROLIDIN-3-YL)-L-CYSTEINAMIDE, (20000 MW)
Pancreatic Cancer
Lumicell, Inc.
P1/2
C
(36)
CHARCOAL ACTIVATED
Breast Cancer Surgery
Fujian Medical University Union Hospital
N/A
D
(30)
CHARCOAL ACTIVATED
Neoadjuvant Therapy
Fujian Medical University Union Hospital
N/A
D
(30)
Cholestyramine
Bariatric Surgery Candidate
Centre Hospitalier Universitaire de Nice
N/A
D
(30)
Cholestyramine
Diabetes
Centre Hospitalier Universitaire de Nice
N/A
D
(30)
Cholestyramine
Obesity, Abdominal
Centre Hospitalier Universitaire de Nice
N/A
D
(30)
Ferumoxytol
Cirrhosis, Liver
University of Wisconsin, Madison
D
(30)
Ferumoxytol
Gastroesophageal Varices
University of Wisconsin, Madison
D
(30)
Ferumoxytol
HCC - Hepatocellular Carcinoma
Université de Montréal
N/A
D
(30)
Ferumoxytol
TACE
Université de Montréal
N/A
D
(30)
HYDROXYETHYL STARCH
Goal Directed Fluid Therapy
Rajiv Gandhi Cancer Institute & Research Center, India
N/A
D
(30)
Tilmanocept
Arterial Inflammation
Massachusetts General Hospital
D
(30)
Tilmanocept
Atherosclerosis
Massachusetts General Hospital
D
(30)
Tilmanocept
Atherosclerotic Cardiovascular Disease
Massachusetts General Hospital
D
(30)
Tilmanocept
Cardiovascular Diseases
Massachusetts General Hospital
D
(30)
Tilmanocept
Carotid Artery Diseases
Massachusetts General Hospital
D
(30)
Tilmanocept
Carotid Atherosclerosis
Massachusetts General Hospital
D
(30)
Tilmanocept
Cerebrovascular Accident
Massachusetts General Hospital
D
(30)
Tilmanocept
Heart Attack
Massachusetts General Hospital
D
(30)
Tilmanocept
Heart Diseases
Massachusetts General Hospital
D
(30)
Tilmanocept
High Cholesterol/Hyperlipidemia
Massachusetts General Hospital
D
(30)
Tilmanocept
Transient Ischemic Attack
Massachusetts General Hospital
D
(30)
Tilmanocept
Vascular Calcification
Massachusetts General Hospital
D
(30)
Tilmanocept
Vascular Disease, Peripheral
Massachusetts General Hospital
D
(30)
Tilmanocept
Vascular Diseases
Massachusetts General Hospital
D
(30)
Showing 76 to 100 of 105 assets
Previous
Page 4 of 5
Next